High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype

Modern Pathology

Volumn 18, Issue 10, 2005, Pages 1289-1294

  Lark, Amy L ^a   Livasy, Chad A ^a,b   Dressler, Lynn ^b   Moore, Dominic T ^b,c   Millikan, Robert C ^b,c   Geradts, Joseph ^d   Iacocca, Mary ^e   Cowan, David ^b   Little, Debbie ^b   Craven, Rolf J ^f   Cance, William ^g,h,i  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e Christiana Care Hospital   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

Breast cancer; Focal adhesion kinase; Immunohistochemistry

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FOCAL ADHESION KINASE; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; EMBEDDING; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; SCORING SYSTEM; TISSUE SECTION; TUMOR PROMOTION; UNITED STATES; UNIVERSITY;

EID: 24944531575     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800424     Document Type: Article

References (39)

1. Garcia-Echeverria C, Fabbro D. Therapeutically targeted anticancer agents: inhibitors of receptor tyrosine kinases. Mini Rev Med Chem 2004;4:273-283.
2. Mass RD. The HER receptor family: a rich target for therapeutic development. Int J Radiat Oncol Biol Phys 2004;58:932-940.
3. Kornberg L, Earp HS, Parsons JT, et al. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 1992;267:23439-23442.
4. Lipfert L, Haimovich B, Schaller MD, et al. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 1992;119:905-912.
5. Schlaepfer DD, Hanks SK, Hunter T, et al. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372:786-791.
6. Guan JL. Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 1997;29:1085-1096.
7. Cary LA, Chang JF, Guan JL. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996;109:1787-1794.
8. Xu LH, Owens LV, Sturge GC, et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 1996;7:413-418.
9. Firsch SM, Vuori K, Ruoslahti E, et al. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996;134:793-799.
10. Hungerford JE, Compton MT, Matter ML, et al. Inhibition of pp125FAK in cultures fibroblasts results in apoptosis. J Cell Biol 1996;135:1383-1390.
11. Schaller MD, Borgman CA, Cobb BS, et al. pp125fak a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992;89:5192-5196.
12. Weiner TM, Liu ET, Craven RJ, et al. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann Surg Oncol 1994;1:18-27.
13. Owens LV, Xu L, Craven RJ, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995;55:2752-2755.
14. Cance WG, Harris JE, Iacocca MV, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000;6:2417-2423.
15. Lightfoot Jr M, Lark A, Livasy CA, et al. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res Treat 2004;88:109-116.
16. Oktay MH, Oktay K, Hamele-Bena D, et al. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. Hum Pathol 2003;34:240-245.
17. Han NM, Fleming RY, Curley SA, et al. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann Surg Oncol 1997;4:264-268.
18. Lark AL, Livasy CA, Calvo B, et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases. Clin Cancer Res 2003;9:215-222.
19. Owens LV, Xu L, Dent GA, et al. The focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996;3:100-105.
20. Judson PL, He X, Cance WG, et al. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 1999;86:1551-1556.
21. Kornberg LJ. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 1998;20:745-752.
22. Miyazaki T, Kato H, Nakajima M, et al. FAK overexpression in correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 2003;89:140-145.
23. Xu LH, Yang X, Bradham CA, et al. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. J Biol Chem 2000;275:30597-30604.
24. Ilic D, Almeida EAC, Schlaepfer DD, et al. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998;143:547-560.
25. Conway K, Edmiston SN, Cui L, et al. evalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 2002;62:1987-1995.
26. Millikan R, Eaton A, Worley K, et al. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat 2003;79:355-364.
27. Furberg H, Millikan R, Dressler L, et al. Tumor characteristics in African American and white women. Breast Cancer Res Treat 2001;68:33-43.
28. Dressler LG, Geradts J, Burroughs M, et al. Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: the UNC SPORE experience. Breast Cancer Res Treat 1999;58:31-39.
29. Muss HB, Thor AD, Berry DA. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260-1266.
30. Millikan R, Pittman G, Newman B. Cigarette smoking, N-acteyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:371-378.
31. Fleming I, Cooper J, Henson D. AJCC Cancer Staging Handbook, 5th edn. Lippincott-Raven: New York, 1998.
32. King CR, Kraus MH, Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 1985;229:974.
33. Slamon DJ, Clark GM, Wong SJ, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182.
34. Slamon DJ, Godolphin W, Jones LA. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989;244:707-712.
35. Vadlamudi RK, Sahin AA, Adam L, et al. Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215. FEBS Lett 2003;543:76-80.
36. Richardson A, Parson TA. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 1996;380:538-540.
37. Golubovskaya VM, Gross S, Kaur AS, et al. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol Cancer Res 2003;10:755-764.
38. Beviglia L, Golubovskaya V, Xu L, et al. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem J 2003;373:201-210.
39. Kurenova E, Xu LH, Yang X, et al. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol Cell Biol 2004;24:4361-4371.